Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Amoxil Vials 500mg Powder for Solution for Injection or Infusion – PA1077/033/004
- Antabuse 400mg Effervescent Tablet – PA1380/008/001
- Colofac 135mg Tablet – PA2010/007/001
- Diazemuls 5mg/ml Emulsion for Injection– PA2315/098/001
- Etoposide Teva 20mg/ml Concentrate for Solution for Infusion – PA0749/002/001
- Genotropin Miniquick 0.4mg Powder and Solvent for Solution for Injection – PA0822/128/004
- Genotropin Miniquick 0.8mg Powder and Solvent for Solution for Injection – PA0822/128/006
- Genotropin Miniquick 1.6mg Powder and Solvent for Solution for Injection – PA0822/128/010
- Keflex 250mg Capsule – PA1226/002/001
- Keflex 500mg Capsule – PA1126/002/004
- Konverge 20mg/5mg Tablet – PA0865/017/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Betnovate RD 0.025% w/w Cream – PA1077/001/004
- Canesten Combi 500mg Pessary & 2% w/w Cream – PA1410/039/001
- Etoposide 20mg/ml Concentrate for Solution for Infusion – PA2315/201/001
- Genotropin 12mg Powder and Solvent for Solution for Injection – PA0822/128/002
- Miochol-E 20mg Powder and Solvent for Instillation Solution for Intraocular Use – PA1245/002/001
- Valsartan Mylan 320mg Tablet – PA0577/134/004
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.